Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengcheng Hao

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Respiratory Disease|August 2, 2019
Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinomaChengcheng Hao, Guiping Liu, Guangliang Tian
Biomedicines|January 21, 2023
Osteopontin and Cancer: Insights into Its Role in Drug ResistanceChengcheng Hao, Jane Lane, Wen G Jiang
Statistical Methods in Medical Research|November 25, 2015
Influence diagnostics for count data under AB-BA crossover trialsChengcheng Hao, Dietrich von Rosen, Tatjana von Rosen
Biomed Research International|July 28, 2016
Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-AnalysisChengcheng Hao, Zhiyan Wang, Yanan Gu, et al.
Cells|August 7, 2021
Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric CancerChengcheng Hao, Yuxin Cui, Jane Lane, et al.
International Journal of Molecular Medicine|April 26, 2017
Human osteopontin: Potential clinical applications in cancer (Review)Chengcheng Hao, Yuxin Cui, Sionen Owen, et al.
Oncotarget|April 21, 2016
The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancerGuifang Du, Yanan Gu, Chengcheng Hao, et al.
Anticancer Research|March 16, 2016
A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR SignalingGuifang DU, Chengcheng Hao, Yanan Gu, et al.
Oncotarget|December 22, 2016
NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathwayYanan Gu, Hefen Yu, Chengcheng Hao, et al.
Clinical Laboratory|August 11, 2020
Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the LiteratureYan Li, Shoubo Yang, Chengcheng Hao, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Respiratory Disease|August 2, 2019
Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinomaChengcheng Hao, Guiping Liu, Guangliang Tian
Biomedicines|January 21, 2023
Osteopontin and Cancer: Insights into Its Role in Drug ResistanceChengcheng Hao, Jane Lane, Wen G Jiang
Statistical Methods in Medical Research|November 25, 2015
Influence diagnostics for count data under AB-BA crossover trialsChengcheng Hao, Dietrich von Rosen, Tatjana von Rosen
Biomed Research International|July 28, 2016
Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-AnalysisChengcheng Hao, Zhiyan Wang, Yanan Gu, et al.
Cells|August 7, 2021
Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric CancerChengcheng Hao, Yuxin Cui, Jane Lane, et al.
International Journal of Molecular Medicine|April 26, 2017
Human osteopontin: Potential clinical applications in cancer (Review)Chengcheng Hao, Yuxin Cui, Sionen Owen, et al.
Oncotarget|April 21, 2016
The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancerGuifang Du, Yanan Gu, Chengcheng Hao, et al.
Anticancer Research|March 16, 2016
A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR SignalingGuifang DU, Chengcheng Hao, Yanan Gu, et al.
Oncotarget|December 22, 2016
NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathwayYanan Gu, Hefen Yu, Chengcheng Hao, et al.
Clinical Laboratory|August 11, 2020
Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the LiteratureYan Li, Shoubo Yang, Chengcheng Hao, et al.
Pageof 2